CLINICAL_TRIALS
trial_result
· 2019-03-29
Clinical Trial Update: Voronistat in Pediatric Patients With Drug Resistant Epilepsy [Phase 2]
Summary
Phase 2 clinical trial update for voronistat in pediatric patients with drug-resistant epilepsy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Calgary | Conditions: Refractory Epilepsy | Phase 2 | Status: UNKNOWN